Introduction Epithelial ovarian cancer (EOC) is the leading cause of mortality among all gynecologic cancers, with over 70% of patients diagnosed at an advanced stage and a 5-year survival rate of approximately 40% (1). Systemic therapy has evolved with the introduction of bevacizumab, a monoclonal antibody targeting vascular endothelial growth fac
Safe Ramadan Practices during COVID-19 - WHO Guidance
6435 Reached8 Comments3 Likes
How Physicians Should Manage Stress?
35294 Reached152 Comments203 Likes
Managing Meconium Aspiration Syndrome in Infants
9817 Reached7 Comments8 Likes
Infant with Congenital Diaphragmatic Hernia (CDH)
6979 Reached14 Comments8 Likes
Case of Increased Risk of Pregnancy-associated Breast Cancer Recurrence
1007 Reached2 Comments